CHRS vs AAPL · rev $26.6M vs P/E 39, rev $416.16B
Coherus BioSciences Inc (CHRS) versus Apple Inc (AAPL) — a side-by-side from cached financials, not a winner call.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
Apple Inc (AAPL) is a consumer electronics company listed on US. It is led by Timothy D. Cook.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
Latest reported AAPL revenue for 2025-09-27 was $416.16B. Net income was $112.01B. Revenue was up 6.4% from 2024-09-28 to 2025-09-27. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
CHRS currently screens at market cap $223.7M. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
Not investment advice. Open the CHRS and AAPL stock pages for the full models.
Not investment advice.